Role of glutamine in cancer: Therapeutic and imaging implications

99Citations
Citations of this article
133Readers
Mendeley users who have this article in their library.

Abstract

Metabolic imaging has great clinical potential in cancer because perturbations of metabolism are common hallmarks of malignant cellular transformation. Novel imaging strategies focused on glutamine could provide a valuable complement to 18F-FDG PET, because glutamine complements glucose in the metabolic platforms that support tumor growth at the cellular level. Furthermore, recent work has demonstrated that distinct aspects of glutamine metabolism are under the control of oncogenes and tumor suppressors. It is plausible that imaging glutamine metabolism could predict both the presence of specific transforming mutations in the tumor and the sensitivity to therapeutic agents designed to target glutamine use. Here, we review the essential aspects of glutamine metabolism in cancer cells and discuss opportunities for imaging in cancer patients. Copyright © 2011 by the Society of Nuclear Medicine, Inc.

Cite

CITATION STYLE

APA

Rajagopalan, K. N., & DeBerardinis, R. J. (2011, July 1). Role of glutamine in cancer: Therapeutic and imaging implications. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.110.084244

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free